Kosei Ojika Selected Research

hippocampal cholinergic neurostimulating peptide

1/2012	Suppression of astrocyte lineage in adult hippocampal progenitor cells expressing hippocampal cholinergic neurostimulating Peptide precursor in an in vivo ischemic model.
2/2009	Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease.
7/2007	Differential expression of HCNP-related antigens in hippocampus in senescence-accelerated mice.
2/2002	Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kosei Ojika Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 12/2009 - 02/2002
3	Stroke (Strokes) 01/2012 - 10/2009
2	Parkinson Disease (Parkinson's Disease) 01/2013 - 05/2012
2	Dementia (Dementias) 07/2007 - 02/2002
1	Multiple System Atrophy 01/2013
1	Brain Ischemia (Cerebral Ischemia) 01/2012
1	Atherosclerotic Plaque (Atheroma) 01/2011
1	Pathologic Constriction (Stenosis) 01/2011
1	Hemorrhage 01/2011
1	Atherosclerosis 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2010
1	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2010
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2009
1	Ischemic Stroke 10/2009
1	Edema (Dropsy) 05/2009
1	Leukocytosis (Pleocytosis) 02/2009
1	Neurolymphomatosis 07/2007
1	Unconsciousness (Loss of Consciousness) 02/2007
1	Thymoma (Thymic Carcinoma) 02/2007
1	Familial cyclic vomiting syndrome 09/2006
1	Migraine Disorders (Migraine) 09/2006
1	Autoimmune Diseases (Autoimmune Disease) 12/2004
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2004
1	Multiple Sclerosis 12/2004
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2002

Drug/Important Bio-Agent (IBA)

4	hippocampal cholinergic neurostimulating peptideIBA 01/2012 - 02/2002
3	Proteins (Proteins, Gene)FDA Link 12/2009 - 02/2002
2	Glucose (Dextrose)FDA LinkGeneric 10/2009 - 07/2007
2	Messenger RNA (mRNA)IBA 02/2009 - 02/2002
1	Dopamine (Intropin)FDA LinkGeneric 01/2013
1	C-Reactive ProteinIBA 01/2011
1	CholesterolIBA 01/2011
1	Hemoglobins (Hemoglobin)IBA 01/2011
1	LipidsIBA 01/2011
1	HDL CholesterolIBA 01/2011
1	LDL CholesterolIBA 01/2011
1	Phenobarbital (Luminal)FDA Link 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Calcium Channels (Calcium Channel)IBA 01/2010
1	Fluorouracil (Carac)FDA LinkGeneric 01/2010
1	Peptides (Polypeptides)IBA 12/2009
1	Tetracycline (Achromycin)FDA LinkGeneric 10/2009
1	Oxygen (Dioxygen)IBA 10/2009
1	Minocycline (Cyclops)FDA LinkGeneric 10/2009
1	Pharmaceutical PreparationsIBA 10/2009
1	Cytochromes c (Cytochrome c)IBA 10/2009
1	Indicators and Reagents (Reagents)IBA 05/2009
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	N-Methylaspartate (NMDA)IBA 07/2007
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 09/2006
1	Amitriptyline (Elavil)FDA LinkGeneric 09/2006
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 12/2004
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2003
1	Donepezil (Aricept)FDA LinkGeneric 03/2003
1	Phosphatidylethanolamine Binding ProteinIBA 02/2002

Therapy/Procedure

3	Therapeutics 01/2013 - 03/2004
1	Transcranial Magnetic Stimulation 01/2013
1	Deep Brain Stimulation 05/2012
1	Thymectomy 02/2007